Thermo Fisher Registers HPLC as FDA Class I Medical Device; Inks Reseller Deal with Prosolia | GenomeWeb

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today said that has listed its Prelude LX-4 MD HPLC as a Class I medical device with the US Food and Drug Administration for general clinical use. 

The firm also said it inked a reseller agreement with Prosolia for that firm's automated sample handling and ionization source for mass spectrometry. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.